• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙胺、芬氟拉明和未标记多巴胺对离体纹状体中[3H]多巴胺释放的比较。

Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

作者信息

Liang N Y, Rutledge C O

出版信息

Biochem Pharmacol. 1982 Mar 15;31(6):983-92. doi: 10.1016/0006-2952(82)90332-x.

DOI:10.1016/0006-2952(82)90332-x
PMID:7082379
Abstract

Amphetamine-induced release of previously accumulated [3H]dopamine ([3H]DA) was compared to the release of [3H]DA produced by unlabelled DA and fenfluramine. Like unlabelled DA, amphetamine was more potent than fenfluramine in releasing [3H]DA in all tissue preparations (untreated, pargyline-treated, and pargyline- and reserpine-treated corpus striatal slices). In tissue treated with both reserpine and pargyline, benztropine greatly reduced the efflux of [3H]DA produced by amphetamine and unlabelled DA but had only a slight effect on fenfluramine-induced release of [3H]DA. In the same tissue preparation, Q10 values for the release of [3H]DA produced by 3 X 10(-7) M amphetamine (1.8) and 3 X 10(-6) M unlabelled DA (1.7) were similar to that for the spontaneous release of [3H]DA (1.7). However, when the concentrations of amphetamine and unlabelled DA were increased to 10(-4) M, the Q10 values for the release of [3H]DA were diminished at the lower temperatures. These results suggest that amphetamine may release [3H]DA by two mechanisms: (1) by accelerated exchange diffusion due to its use of the DA uptake carrier to enter into neurons (this would predominate at low concentrations of amphetamine), and (2) by passive entrance into neurons and displacement of [3H]DA from binding sites (this would predominate at high concentrations of amphetamine).

摘要

将苯丙胺诱导的先前积累的[3H]多巴胺([3H]DA)释放与未标记的多巴胺和芬氟拉明产生的[3H]DA释放进行了比较。与未标记的多巴胺一样,在所有组织制剂(未处理、帕吉林处理、帕吉林和利血平处理的纹状体切片)中,苯丙胺在释放[3H]DA方面比芬氟拉明更有效。在用利血平和帕吉林处理的组织中,苯海索大大减少了苯丙胺和未标记的多巴胺产生的[3H]DA流出,但对芬氟拉明诱导的[3H]DA释放只有轻微影响。在相同的组织制剂中,3×10^(-7) M苯丙胺(1.8)和3×10^(-6) M未标记的多巴胺(1.7)产生的[3H]DA释放的Q10值与[3H]DA的自发释放(1.7)相似。然而,当苯丙胺和未标记的多巴胺浓度增加到10^(-4) M时,在较低温度下[3H]DA释放的Q10值降低。这些结果表明,苯丙胺可能通过两种机制释放[3H]DA:(1)通过利用多巴胺摄取载体进入神经元而加速交换扩散(在低浓度苯丙胺时占主导),以及(2)通过被动进入神经元并从结合位点置换[3H]DA(在高浓度苯丙胺时占主导)。

相似文献

1
Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.苯丙胺、芬氟拉明和未标记多巴胺对离体纹状体中[3H]多巴胺释放的比较。
Biochem Pharmacol. 1982 Mar 15;31(6):983-92. doi: 10.1016/0006-2952(82)90332-x.
2
Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.苯环利定、苯丙胺及相关化合物对纹状体突触体多巴胺释放及摄取的影响。
J Pharmacol Exp Ther. 1984 Jun;229(3):671-80.
3
Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.马吲哚和苯丙胺作为大鼠纹状体突触体对3H-多巴胺摄取及释放的抑制剂。
Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):1-5. doi: 10.1007/BF00510979.
4
Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.在存在帕吉林的情况下,痕量胺抑制大鼠纹状体切片中[3H]乙酰胆碱的电诱发释放:β-苯乙胺与苯丙胺之间的相似性。
J Pharmacol Exp Ther. 1985 Oct;235(1):220-9.
5
Release of 3H-dopamine and analogous monoamines from rat striatal tissue.3H-多巴胺及类似单胺从大鼠纹状体组织中的释放。
Cell Mol Neurobiol. 1988 Jun;8(2):205-16. doi: 10.1007/BF00711246.
6
Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.d-苯丙胺和多巴胺合成抑制剂对纹状体中多巴胺和乙酰胆碱神经传递的影响。I. 无囊泡递质储存时的释放
J Pharmacol Exp Ther. 1986 Apr;237(1):179-92.
7
Effects of acute and chronic administration of cocaine on striatal uptake, compartmentalization and release of [3H]dopamine.急性和慢性给予可卡因对纹状体[3H]多巴胺摄取、区室化和释放的影响。
Neuropharmacology. 1990 May;29(5):475-86. doi: 10.1016/0028-3908(90)90170-v.
8
Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum.采用双标记法同时评估药物诱导的大鼠纹状体突触体标本中多巴胺摄取抑制和释放情况。
Biochem Pharmacol. 1984 Jul 1;33(13):2129-35. doi: 10.1016/0006-2952(84)90583-5.
9
Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.苯丙胺:对d-和l-异构体作为大鼠新纹状体和大脑皮质切片中3H-多巴胺和3H-去甲肾上腺素释放剂及摄取抑制剂的评价。
J Pharmacol Exp Ther. 1975 Jul;194(1):47-56.
10
[3H]Dopamine accumulation and release from striatal slices in young, mature and senescent rats.年轻、成熟和衰老大鼠纹状体切片中[3H]多巴胺的积累与释放
Brain Res. 1981 Nov 16;224(2):436-40. doi: 10.1016/0006-8993(81)90874-x.

引用本文的文献

1
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats.囊泡单胺转运体 2 抑制剂 JPC-141 可预防甲基苯丙胺诱导的多巴胺毒性并阻断大鼠的甲基苯丙胺自我给药。
Biochem Pharmacol. 2024 Oct;228:116189. doi: 10.1016/j.bcp.2024.116189. Epub 2024 Apr 3.
2
Organic cation transporters in psychiatric and substance use disorders.精神疾病和物质使用障碍中的有机阳离子转运体。
Pharmacol Ther. 2024 Jan;253:108574. doi: 10.1016/j.pharmthera.2023.108574. Epub 2023 Dec 9.
3
Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter-mediated nonquantal dopamine release.
模拟信号对神经递质相互作用和行为的贡献:转运体介导的非量子多巴胺释放的作用。
Physiol Rep. 2021 Nov;9(21):e15088. doi: 10.14814/phy2.15088.
4
An unsuspected role for organic cation transporter 3 in the actions of amphetamine.有机阳离子转运体 3 在安非他命作用中的一个未被预料的角色。
Neuropsychopharmacology. 2018 Nov;43(12):2408-2417. doi: 10.1038/s41386-018-0053-5. Epub 2018 Apr 6.
5
Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.含有4-羟基和4-(2-氟乙氧基)芳基取代基的洛贝林类似物:对囊泡单胺转运体-2上[(3)H]多巴胺摄取具有强效和选择性的抑制剂
Bioorg Med Chem Lett. 2016 May 15;26(10):2422-2427. doi: 10.1016/j.bmcl.2016.03.119. Epub 2016 Apr 1.
6
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.多巴胺与囊泡单胺转运体的调控:药理学靶点及其对疾病的影响
Pharmacol Rev. 2015 Oct;67(4):1005-24. doi: 10.1124/pr.114.010397.
7
Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens.氩通过伏隔核中囊泡单胺转运体2和μ-阿片受体的拮抗作用,阻断对苯丙胺运动致敏的表达。
Transl Psychiatry. 2015 Jul 7;5(7):e594. doi: 10.1038/tp.2015.27.
8
Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patients.可卡因调节原代CD4+T细胞中HIV-1的整合:对药物滥用患者HIV-1发病机制的影响。
J Leukoc Biol. 2015 Apr;97(4):779-90. doi: 10.1189/jlb.4A0714-356R. Epub 2015 Feb 17.
9
Biphasic mechanisms of amphetamine action at the dopamine terminal.安非他命作用于多巴胺末梢的双相机制。
J Neurosci. 2014 Apr 16;34(16):5575-82. doi: 10.1523/JNEUROSCI.4050-13.2014.
10
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.囊泡单胺转运体-2:发现治疗甲基苯丙胺滥用新疗法的重要药理学靶点。
Adv Pharmacol. 2014;69:71-106. doi: 10.1016/B978-0-12-420118-7.00002-0.